NewAmsterdam Pharma Company N.V

Q4 2025 13F Holders

Symbol
NAMS
CUSIP
N62509109
Type
Equity
Class
ORDINARY SHARES
Num filings
195
Total reported value, excl. options
$4.13 B
Manager Report Date Value ($000) Shares Option Type